Connect with us

Markets

Chinese public telecom provider Coolpad Group allocates $13.5m to buy Bitcoin mining rigs

Published

on

Shenzhen-headquartered telecommunications equipment company Coolpad Group has announced the purchase of $13.5 million worth of crypto mining rigs.

Coolpad Group, a public Chinese telecom provider listed on the Hong Kong Stock Exchange, said in a regulatory filing it has allocated over HK$106 million (around $13.5 million) to purchase Bitcoin mining rigs as the firm now “actively pursues opportunities in web 3.0 digital currency business.”

Chinese public telecom provider Coolpad Group allocates $13.5m to buy Bitcoin mining rigs - 1

As per the document, Coolpad plans to acquire 2,700 crypto mining rigs from Hong Kong-based JingYun Intelligent Technology Limited, with deployment slated for North America. The document doesn’t specify the manufacturer of the equipment. This investment aims to boost Coolpad’s current computing power from 873,000 TH/s to an estimated 1,504,800 TH/s.

You might also like: Make bitcoin mining stocks great again? Trump calls for US mining dominance

The transaction is expected to be completed within three months, the document said.

Coolpad Group initially unveiled its focus towards crypto in early May, revealing a $28 million investment plan aimed at acquiring shares of publicly traded Bitcoin mining companies listed on Nasdaq. The company specified its interest in acquiring shares of entities such as CleanSpark (CLSK), ARK 21Shares Bitcoin ETF (ARKB), Bitwise Bitcoin ETF (BITB), Grayscale Bitcoin Trust (GBTC), and Hashdex Bitcoin Futures ETF (DEFI), among others.

Highlighting the current market trends and the promising future of blockchain technology and crypto assets, Coolpad emphasized in a regulatory filing that investments in listed securities within the crypto sector present an “opportunity” to expand its digital currency business.

Read more: Bitfarms stock up 15% after announcing large-scale mining site

Markets

China iPhone's reductions are 'extra beneficiant' than these on Android fashions: Jefferies

Published

on

China’s smartphone quantity continued to develop year-over-year following the 618 promotions, pushed by beneficiant reductions, Jefferies mentioned in a Sunday observe.

Citing trade checks, Jefferies analysts mentioned smartphone quantity fell by low double digits sequentially however nonetheless posted excessive single-digit year-over-year progress. This progress was pushed by excessive single-digit good points in Android and Huawei (HW) gadgets and low double-digit good points in iPhone gross sales. Notably, iPhone gross sales continued to outpace Android and HW through the 618 interval.

“Our trade checks counsel that, YTD, China’s smartphone market grew 3%+ YoY, pushed by HSD progress in Android+HW, however LDD decline in iPhone,” analysts wrote.

“iPhone has regained some floor up to now month pushed by extra beneficiant reductions,” they added.

Jefferies estimates that Huawei has been the largest market share gainer year-over-year up to now in 2024, whereas OPPO has misplaced essentially the most share. iPhone’s market share has solely declined barely, by lower than one proportion level, year-over-year.

Jefferies’ evaluation additionally confirmed that iPhone reductions final week remained largely just like these through the 618 promotions on JD (NASDAQ:) and PDD platforms. Nonetheless, there was a rise in reductions particularly for the iPhone 15 and 15+ on JD, Suning, and PDD.

For Android and Huawei gadgets, reductions usually retreated after 618. Nonetheless, PDD continued to supply vital reductions on the 5 Android and HW flagship fashions that Jefferies screens. Outdoors of PDD, most platforms have lowered their reductions following the 618 gross sales occasion.

“Due to this fact, iPhone’s reductions are principally extra beneficiant than these on Android+HW flagship fashions,” analysts continued.

“Which will clarify iPhone’s continued outperformance towards Android+HW. We see that as a robust signal that every one smartphone makers are very eager to defend market share on the excessive finish, and high-end fashions normally have greater GM, which implies room for discounting.

Continue Reading

Markets

30% of My Portfolio Is Invested in Simply 5 Shares — Right here's Precisely What They Are

Published

on

I usually haven’t got a ton of focus in my portfolio, however on account of current market strikes, greater than 30% of my capital is invested in simply 5 shares. Some are frequent slow-and-steady portfolio spine shares, whereas others may shock you. This is a rundown of what all 5 are.

*Inventory costs used have been the morning costs of July 2, 2024. The video was revealed on July 3, 2024.

Must you make investments $1,000 in Berkshire Hathaway proper now?

Before you purchase inventory in Berkshire Hathaway, think about this:

The Motley Idiot Inventory Advisor analyst workforce simply recognized what they consider are the  for traders to purchase now… and Berkshire Hathaway wasn’t certainly one of them. The ten shares that made the reduce may produce monster returns within the coming years.

Think about when Nvidia made this record on April 15, 2005… when you invested $1,000 on the time of our suggestion, you’d have $771,034!*

Inventory Advisor offers traders with an easy-to-follow blueprint for achievement, together with steering on constructing a portfolio, common updates from analysts, and two new inventory picks every month. The Inventory Advisor service has greater than quadrupled the return of S&P 500 since 2002*.

*Inventory Advisor returns as of July 2, 2024

has positions in Berkshire Hathaway, Normal Motors, MercadoLibre, Pinterest, and Realty Revenue. The Motley Idiot has positions in and recommends Berkshire Hathaway, MercadoLibre, Pinterest, and Realty Revenue. The Motley Idiot recommends Normal Motors and recommends the next choices: lengthy January 2025 $25 calls on Normal Motors. The Motley Idiot has a .

Matthew Frankel is an affiliate of The Motley Idiot and could also be compensated for selling its companies. In the event you select to subscribe by way of they may earn some extra cash that helps their channel. Their opinions stay their very own and are unaffected by The Motley Idiot.

was initially revealed by The Motley Idiot

Continue Reading

Markets

Eli Lilly to purchase bowel illness drug developer Morphic for $3.2 billion

Published

on

© Reuters. FILE PHOTO: Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo

(Reuters) -Eli Lilly will purchase Morphic Holding (NASDAQ:) for $3.2 billion in money, the businesses mentioned on Monday, giving the U.S. drugmaker entry to an experimental drug for sorts of inflammatory bowel illnesses.

Shares of drug developer Morphic surged 76% to $56.15 premarket on Lilly’s provide of $57 per share, which represents a 79% premium to inventory’s final closing worth.

Morphic’s lead drug MORF-057 is an oral remedy that’s being evaluated in two section 2 research in ulcerative colitis sufferers and one section 2 examine in Crohn’s illness.

Ulcerative colitis is a situation the place irregular reactions of the immune system trigger irritation and ulcers on the inside lining of the colon, which may result in diarrhea, passing of blood with stool and belly ache.

Final yr, the U.S. Meals and Drug Administration accepted Lilly’s Omvoh for treating adults with moderate-to-severe lively ulcerative colitis.

The drug is amongst Lilly’s potential development drivers for this decade alongside its diabetes and weight problems medicine, Mounjaro and Zepbound.

Different drugmakers comparable to Abbvie Inc, Pfizer (NYSE:) and Johnson & Johnson (NYSE:) are additionally jostling for a share of the multi-billion greenback bowel illness market.

Continue Reading

Trending